{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T19:21:47Z","timestamp":1770146507607,"version":"3.49.0"},"reference-count":26,"publisher":"Medical Association of Nippon Medical School","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Nippon Med Sch"],"published-print":{"date-parts":[[2025,12,20]]},"DOI":"10.1272\/jnms.jnms.2025_92-605","type":"journal-article","created":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T22:09:50Z","timestamp":1767996590000},"page":"450-456","source":"Crossref","is-referenced-by-count":1,"title":["Deep Cerebral Vein Thrombosis Triggered by Contraceptive Use in a Woman with Non-Overt Essential Thrombocythemia"],"prefix":"10.1272","volume":"92","author":[{"given":"Po-Jen","family":"Hsu","sequence":"first","affiliation":[{"name":"Stroke Center and Department of Neurology, Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chih-Hao","family":"Chen","sequence":"additional","affiliation":[{"name":"Stroke Center and Department of Neurology, National Taiwan University Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinn-Kuang","family":"Lin","sequence":"additional","affiliation":[{"name":"Stroke Center and Department of Neurology, Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation"},{"name":"School of Medicine, Tzu Chi University"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"21","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Canhao P, Ferro JM, Lindgren AG, et al. Causes and predictors of death in cerebral venous thrombosis. Stroke. 2005 Aug;36 (8):1720-5.","DOI":"10.1161\/01.STR.0000173152.84438.1c"},{"key":"2","unstructured":"2. Saposnik G, Bushnell C, Coutinho JM, et al. Diagnosis and management of cerebral venous thrombosis: A scientific statement from the American Heart Association. Stroke. 2024 Mar;55 (3):e77-90."},{"key":"3","unstructured":"3. Linn J, Ertl-Wagner B, Seelos KC, et al. Diagnostic value of multidetector-row CT angiography in the evaluation of thrombosis of the cerebral venous sinuses. AJNR Am J Neuroradiol. 2007 May;28 (5):946-52."},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Tayyebi S, Akhavan R, Shams M, et al. Diagnostic value of non-contrast brain computed tomography in the evaluation of acute cerebral venous thrombosis. Sci Rep. 2020 Jan 21;10 (1):883.","DOI":"10.1038\/s41598-020-57867-1"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Vijay RK. The cord sign. Radiology. 2006 Jul;240 (1):299-300.","DOI":"10.1148\/radiol.2401031739"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Linn J, Pfefferkorn T, Ivanicova K, et al. Noncontrast CT in deep cerebral venous thrombosis and sinus thrombosis: Comparison of its diagnostic value for both entities. AJNR Am J Neuroradiol. 2009 Apr;30 (4):728-35.","DOI":"10.3174\/ajnr.A1451"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Calandrelli R, Colo F, Broccolini A, et al. Deep cerebral venous system involvement in patients with cerebral sinus thrombosis. A proposal of neuroradiological score systems useful for clinical assessment. Neurol Sci. 2023 Jun;44 (6):2049-60.","DOI":"10.1007\/s10072-023-06656-5"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Stegeman BH, de Bastos M, Rosendaal FR, et al. Different combined oral contraceptives and the risk of venous thrombosis: Systematic review and network meta-analysis. BMJ. 2013 Sep 12;347:f5298.","DOI":"10.1136\/bmj.f5298"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. LaVasseur C, Neukam S, Kartika T, Samuelson Bannow B, Shatzel J, DeLoughery TG. Hormonal therapies and venous thrombosis: Considerations for prevention and management. Res Pract Thromb Haemost. 2022 Aug 23;6 (6):e12763.","DOI":"10.1002\/rth2.12763"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Amoozegar F, Ronksley PE, Sauve R, Menon BK. Hormonal contraceptives and cerebral venous thrombosis risk: A systematic review and meta-analysis. Front Neurol. 2015 Feb 2;6:7.","DOI":"10.3389\/fneur.2015.00007"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Gomes MP, Deitcher SR. Risk of venous thromboembolic disease associated with hormonal contraceptives and hormone replacement therapy: A clinical review. Arch Intern Med. 2004 Oct 11;164 (18):1965-76.","DOI":"10.1001\/archinte.164.18.1965"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. van Hylckama Vlieg A, Helmerhorst FM, Vandenbroucke JP, Doggen CJ, Rosendaal FR. The venous thrombotic risk of oral contraceptives, effects of oestrogen dose and progestogen type: Results of the MEGA case-control study. BMJ. 2009 Aug 13;339:b2921.","DOI":"10.1136\/bmj.b2921"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Barbui T, Carobbio A, De Stefano V. Thrombosis in myeloproliferative neoplasms during cytoreductive and antithrombotic drug treatment. Res Pract Thromb Haemost. 2022 Feb 7;6 (1):e12657.","DOI":"10.1002\/rth2.12657"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Martinelli I, De Stefano V, Carobbio A, et al. Cerebral vein thrombosis in patients with Philadelphia-negative myeloproliferative neoplasms. An European Leukemia Net study. Am J Hematol. 2014 Nov;89 (11):E200-5.","DOI":"10.1002\/ajh.23809"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Klampfl T, Gisslinger H, Harutyunyan AS, et al. Somatic mutations of calreticulin in myeloproliferative neoplasms. New Engl J Med. 2013 Dec 19;369 (25):2379-90.","DOI":"10.1056\/NEJMoa1311347"},{"key":"16","doi-asserted-by":"publisher","unstructured":"16. Carobbio A, Thiele J, Passamonti F, et al. Risk factors for arterial and venous thrombosis in WHO-defined essential thrombocythemia: An international study of 891 patients. Blood. 2011 Jun 2;117 (22):5857-9.","DOI":"10.1182\/blood-2011-02-339002"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. De Stefano V, Fiorini A, Rossi E, et al. Incidence of the JAK2 V617F mutation among patients with splanchnic or cerebral venous thrombosis and without overt chronic myeloproliferative disorders. J Thromb Haemost. 2007 Apr;5 (4):708-14.","DOI":"10.1111\/j.1538-7836.2007.02424.x"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Gangat N, Wolanskyj AP, Schwager SM, Mesa RA, Tefferi A. Estrogen-based hormone therapy and thrombosis risk in women with essential thrombocythemia. Cancer. 2006 Jun 1;106 (11):2406-11.","DOI":"10.1002\/cncr.21891"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Kemmeren JM, Algra A, Meijers JC, et al. Effect of second- and third-generation oral contraceptives on the protein C system in the absence or presence of the factor VLeiden mutation: A randomized trial. Blood. 2004 Feb 1;103 (3):927-33.","DOI":"10.1182\/blood-2003-04-1285"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Bucalossi A, Marotta G, Bigazzi C, Galieni P, Dispensa E. Reduction of antithrombin III, protein C, and protein S levels and activated protein C resistance in polycythemia vera and essential thrombocythemia patients with thrombosis. Am J Hematol. 1996 May;52 (1):14-20.","DOI":"10.1002\/(SICI)1096-8652(199605)52:1<14::AID-AJH3>3.0.CO;2-9"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Yousaf Q, Khan HA, Ata F, Khan AA, Karim N, Yousaf Z. Cerebral venous sinus thrombosis as the initial presentation of essential thrombocythemia - A case report and literature review. eNeurologicalSci. 2022 Mar 31;27:100398.","DOI":"10.1016\/j.ensci.2022.100398"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Chen WB, Wang XL. Cerebral venous sinus thrombosis as the first manifestation of JAK2<sup>V617F<\/sup>-positive essential thrombocythemia. Chin Med J (Engl). 2018 Mar 20;131 (6):748-50.","DOI":"10.4103\/0366-6999.226903"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Richard S, Perrin J, Lavandier K, Lacour JC, Ducrocq X. Cerebral venous thrombosis due to essential thrombocythemia and worsened by heparin-induced thrombocytopenia and thrombosis. Platelets. 2011;22 (2):157-9.","DOI":"10.3109\/09537104.2010.527399"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Messouak O, Alaoui Faris M, Benabdejlil M, Tizniti S, Belahsen F. Thrombose veineuse cerebrale secondaire a une thrombocytemie essentielle [Cerebral venous thrombosis secondary to essential thrombocythemia]. Rev Neurol (Paris). 2007 May;163 (5):596-8. French.","DOI":"10.1016\/S0035-3787(07)90467-1"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Green M, Styles T, Russell T, et al. Non-genetic and genetic risk factors for adult cerebral venous thrombosis. Thromb Res. 2018 Sep;169:15-22.","DOI":"10.1016\/j.thromres.2018.07.005"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Tefferi A, Vannucchi AM, Barbui T. Essential thrombocythemia treatment algorithm 2018. Blood Cancer J. 2018;8 (1):2.","DOI":"10.1038\/s41408-017-0041-8"}],"container-title":["Journal of Nippon Medical School"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jnms\/92\/6\/92_JNMS.2025_92-605\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T04:04:22Z","timestamp":1768017862000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jnms\/92\/6\/92_JNMS.2025_92-605\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,20]]},"references-count":26,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1272\/jnms.jnms.2025_92-605","relation":{},"ISSN":["1345-4676","1347-3409"],"issn-type":[{"value":"1345-4676","type":"print"},{"value":"1347-3409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,20]]},"article-number":"JNMS.2025_92-605"}}